CPIX
CUMBERLAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.70
−6.69%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.13
- Revenue estimate
- $8.5M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.13
- Revenue actual
- —
- Revenue estimate
- $8.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -259.4%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.13 | -$0.20 | Miss -53.85% | — |
| May 5, 2026 | -$0.13 | -$0.13 | In line | $9.1M |
| Mar 3, 2026 | — | -$0.01 | — | $13.7M |
| Nov 4, 2025 | — | -$0.06 | — | $8.3M |
| Mar 4, 2025 | — | -$0.02 | — | $10.4M |
| Nov 7, 2024 | — | -$0.02 | — | $9.1M |
| Mar 5, 2024 | — | -$0.11 | — | $9.4M |
| Mar 7, 2023 | — | -$0.05 | — | $9.1M |
| Mar 8, 2022 | -$0.01 | -$0.13 | Miss -1200.00% | $8.3M |
| Aug 10, 2021 | -$0.07 | $0.08 | Beat 216.16% | $9.1M |
| Mar 9, 2021 | $0.00 | $0.01 | Beat 200.30% | $10.3M |
| Nov 10, 2020 | -$0.07 | $0.02 | Beat 128.57% | $9.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026